Delivery Order SPE2DB22D3011-SPE2DB24FQ2KU

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,888,596 units of the drug clobazam 10 mg tablets. The contract has a ceiling value of $17,460.60 and a completion date of April 14, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,528,749 units of the medication clobazam 10 mg tablets, with a ceiling value of $1,555.93. The contract has an ultimate completion date of November 25, 2024, and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,268,948 units of clobazam 10 mg tablets. The contract has a ceiling value of $3,454.26 and a completion date of February 14, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,111.86 firm fixed-price contract is for the delivery of 4,565,120 units of the prescription drug Clobazam 10 mg tablets. The contract has an ultimate completion date of July 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $19,133.41, is for the purchase of 4,567,156,449 units of the pharmaceutical drug Clobazam 10 mg tablets. The contract is a firm fixed-price delivery order with a completion date of February 5, 2025. Amerisourcebergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,853.88, is for the supply of 4,566,719,361 units of the generic drug Clobazam 10 mg tablets. The contract has a completion date of December 16, 2024 and is a firm fixed-price type. It was not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,955,772 tablets of the medication Clobazam 10 mg, with a total ceiling value of $7,593.04. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 18, 2025. This order is not associated with any set-aside program and was competitively...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 tablets of the medication Clobazam 10 mg. The contract has a firm fixed price of $3,111.86 and a completion date of June 6, 2025. The award is not set-aside and was made on June 5, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,203,066 units of the pharmaceutical drug clobazam 10 mg tablets in 100-count bottles. The contract has a ceiling value of $2,526.62 and a period of performance ending on May 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,820.13 for the supply of 4,565,563,070 units of the prescription drug Clobazam 10 mg tablet. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 26, 2024. The contract is a firm fixed-price delivery order and does not utilize any set-aside designations. AmerisourceBergen holds a larger Indefinite...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FQ2KU
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,086 units of the drug clobazam 10 mg tablets. The contract has a ceiling value of $1,564.87 and a period of performance through July 9, 2024. It is a firm fixed-price contract and was not set aside for any specific business type.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/17/25, 10:01 AM